Bill 119 HR 2172, also known as the Home Infusion Therapy Access Act, aims to make changes to the Medicare program in order to ensure that patients have continued access to home infusion therapy. This type of therapy allows patients to receive necessary medications and treatments in the comfort of their own homes, rather than having to go to a medical facility.
The bill seeks to clarify the original intent of Congress regarding home infusion therapy under Medicare, as there have been some uncertainties and challenges in recent years. By making these clarifications, the bill aims to ensure that patients can continue to receive this important form of treatment without interruption.
In addition to clarifying congressional intent, the bill also includes provisions to address issues related to reimbursement for home infusion therapy services. This is important in order to ensure that providers are adequately compensated for the care they provide to patients.
Overall, the Home Infusion Therapy Access Act is focused on preserving patient access to home infusion therapy under Medicare and addressing any challenges that may arise in the delivery of this important form of treatment.